Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2).

Authors:
Soojin Lee Jingu Gang Sun Bok Jeon Seung Ho Choo Bogman Lee Young-Gun Kim Yang Soon Lee Jinyoung Jung Si Young Song Sang Seok Koh

Biochem Biophys Res Commun 2007 Aug 28;360(3):633-9. Epub 2007 Jun 28.

Department of Microbiology, Chungnam National University, Daejeon 305-764, Republic of Korea.

We examined genome-wide differences in gene expression between tumor biopsies and normal tissues in order to identify differentially regulated genes in tumors. Cancer-upregulated gene 2 (CUG2) was identified as an expressed sequence tag (EST) that exhibits significant differential expression in multiple human cancer types. CUG2 showed weak sequence homology with the down-regulator of transcription 1 (DR1) gene, a human transcription repressor. We found that EGFP-CUG2 fusion proteins were predominantly localized in the nucleus, suggesting their putative role in gene regulation. In addition, CUG2-overexpressing mouse fibroblast cells exhibited distinct cancer-specific phenotypes in vitro and developed into tumors in nude mice. Taken together, these findings suggest that CUG2 is a novel tumor-associated gene that is commonly activated in various human cancers and exhibits high transforming activities; it possibly belongs to a transcription regulator family that is involved in tumor biogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.06.102DOI Listing
August 2007

Publication Analysis

Top Keywords

cancer-upregulated gene
8
gene cug2
8
gene
6
suggesting putative
4
nucleus suggesting
4
localized nucleus
4
fusion proteins
4
proteins localized
4
putative role
4
role gene
4
mouse fibroblast
4
fibroblast cells
4
cug2-overexpressing mouse
4
addition cug2-overexpressing
4
gene regulation
4
regulation addition
4
egfp-cug2 fusion
4
transcription repressor
4
sequence homology
4
homology down-regulator
4

Altmetric Statistics


Show full details
1 Total Shares
1 Citations

Similar Publications

Overexpression of Cancer Upregulated Gene 2 (CUG2) Decreases Spry2 Through c-Cbl, Leading to Activation of EGFR and β-Catenin Signaling.

Authors:
Natpaphan Yawut Chutima Kaewpiboon Phatcharaporn Budluang Il-Rae Cho Sirichat Kaowinn Sang Seok Koh Young-Hwa Chung

Cancer Manag Res 2020 15;12:10243-10250. Epub 2020 Oct 15.

BK21 Plus, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan 46241, Republic of Korea.

Purpose: The mechanism by which cancer upregulated gene 2 (CUG2) overexpression induces cancer stem cell-like phenotypes is not fully understood. Because the increased activity and expression of epidermal growth factor receptor (EGFR) kinase have been reported in A549 cancer cells overexpressing CUG2 (A549-CUG2) compared with control cells (A549-Vec), the Sprouty2 (Spry2) protein has gained attention as the downstream molecule of EGFR signaling. Therefore, we aim to identify the role of Spry2 in CUG2-overexpressing lung cancer cells. Read More

View Article and Full-Text PDF
October 2020
Similar Publications

Overexpression of long noncoding RNA CUDR promotes hepatic differentiation of human umbilical cord mesenchymal stem cells.

Authors:
Yabin Yu Meng Li Yan Song Jianbo Xu Fuzhen Qi

Mol Med Rep 2020 Mar 19;21(3):1051-1058. Epub 2019 Dec 19.

Department of Hepatobiliary Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu 223300, P.R. China.

Previous studies have shown that long noncoding RNAs (lncRNAs) are capable of regulating cell differentiation and pluripotency. The objective of the present study was to explore the effect of lncRNA cancer upregulated drug resistant (CUDR) on the hepatic differentiation of human umbilical cord mesenchymal stem cells (HuMSCs). HuMSCs were subjected to a hepatogenic differentiation protocol. Read More

View Article and Full-Text PDF
March 2020
Similar Publications

Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis.

Authors:
Sirichat Kaowinn Eun Jin Seo Woong Heo Jae-Ho Bae Eun-Jung Park Soojin Lee Yeon Jeong Kim Sang Seok Koh Il Ho Jang Dong Hoon Shin Young-Hwa Chung

Biochem Biophys Res Commun 2019 07 18;514(4):1278-1284. Epub 2019 May 18.

BK21+, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan, 46241, Republic of Korea. Electronic address:

Our previous study reported that cancer upregulated gene (CUG)2, a novel oncogene, induces both faster cell migration and anti-cancer drug resistance. We thus wonder whether CUG2 also induces stemness, a characteristic of cancer stem cells (CSCs) and further examine the molecular mechanism of this phenotype. To test that CUG2 induces stemness, we examined expression of stemness-related factors. Read More

View Article and Full-Text PDF
July 2019
Similar Publications

CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin.

Authors:
Sirichat Kaowinn Sangtaek Oh Jeong Moon Ah Young Yoo Ho Young Kang Mi Rim Lee Ji Eun Kim Dae Youn Hwang So Eun Youn Sang Seok Koh Young-Hwa Chung

Int J Oncol 2019 Apr 22;54(4):1295-1305. Epub 2019 Feb 22.

BK21 Plus, Department of Cogno‑Mechatronics Engineering, Pusan National University, Busan 46241, Republic of Korea.

The mechanisms through which cancer‑upregulated gene 2 (CUG2), a novel oncogene, affects Wnt/β‑catenin signaling, essential for tumorigenesis, are unclear. In this study, we aimed to elucidate some of these mechanisms in A549 lung cancer cells. Under the overexpression of CUG2, the protein levels and activity of β‑catenin were evaluated by western blot analysis and luciferase assay. Read More

View Article and Full-Text PDF
April 2019
Similar Publications

Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells.

Authors:
Sirichat Kaowinn Natpaphan Yawut Sang Seok Koh Young-Hwa Chung

Biochem Biophys Res Commun 2019 03 14;511(1):122-128. Epub 2019 Feb 14.

BK21 Plus, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan, 46241, Republic of Korea. Electronic address:

Although our previous studies have showed that a novel oncogene, cancer upregulated gene (CUG)2 induced epithelial-mesenchymal transition (EMT), the detailed molecular mechanism remains unknown. Because several lines of evidence documented that Yes-Associated Protein (YAP)1 is closely associated with cancer stem cell (CSC)-like phenotypes including EMT, stemness, and drug resistance, we wondered if YAP1 is involved in CUG2-induced EMT. We herein found that the overexpression of CUG2 increased YAP1 expression at the transcriptional as well as protein levels. Read More

View Article and Full-Text PDF
March 2019
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap